Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 12/22/16 → 7/31/25 |
Funding
- 3V Biosciences Incorporated: $25,000.00
MCC-16-MULTI-22-PMC: Pharmacodynamic Effects of Fatty Acid Synthase (FASN) Inhibition with TVB-2640 in Resectable Colon and Other Resectable Cancers: A Window Trial
- Evers, B. Mark (PI)
- Zaytseva, Yekaterina (CoI)